$TPTX Turning Point Therapeutics, Inc. Insiders

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Turning Point Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of current and past insiders in Turning Point Therapeutics, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.

Turning Point Therapeutics, Inc. Insiders

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Baker Brian LeeVP of Finance and Admin.3,0160shares bought: 3,016 / shares sold: 0 STRONG BUYJan 08 20203 months ago
Chacko JacobDirector00Apr 24 201912 months ago
Cormorant Asset Management, LLC10% Owner3,122,3670shares bought: 423,268 / shares sold: 0 STRONG BUYMay 16 201911 months ago
Countouriotis AthenaPresident & CEO22,7060shares bought: 22,706 / shares sold: 0 STRONG BUYJan 08 20203 months ago
Cui Jingrong JeanDirector786,9910shares bought: 109,164 / shares sold: -613,292 STRONG SELLMar 27 202012 days ago
Gallagher Carol GiltnerDirector00Jul 25 20199 months ago
George SimeonDirector2,170,3270shares bought: 2,170,327 / shares sold: 0 STRONG BUYSep 11 20197 months ago
GLAXOSMITHKLINE PLCDirector2,170,3270shares bought: 2,170,327 / shares sold: 0 STRONG BUYSep 12 20197 months ago
GORDON CARL LDirector1,120,7300shares bought: 2,027,550 / shares sold: 0 STRONG BUYApr 24 201912 months ago
Gujrathi SheilaDirector00Apr 24 201912 months ago
Hirmand MohammadEVP and Chief Medical Officer00Dec 03 20194 months ago
Larson YiEVP & Chief Financial Officer2,2220shares bought: 2,222 / shares sold: 0 BUYJan 08 20203 months ago
Lu HongboDirector1,120,7300shares bought: 1,727,550 / shares sold: 0 STRONG BUYApr 24 201912 months ago
Nicholson Garry ADirector00Jan 23 20203 months ago
North AnnetteEVP, General Counsel & Secty.00Jan 08 20203 months ago
ORBIMED ADVISORS LLCDirector1,120,7300shares bought: 2,027,550 / shares sold: 0 STRONG BUYApr 24 201912 months ago
Reich SiegfriedEVP & Chief Scientific Officer00Mar 02 20201 month ago